Languita, Gelmar O.
HRN: 24-08-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
CEFUROXIME 1.5GM (VIAL)
11/16/2023
11/23/2023
IV
1.5grams
Q8H
Soft Tissue Injuries Sec To MVA; T/c TBI
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes